Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment

Viktor Gr├╝nwald*, Axel S. Merseburger

*Corresponding author for this work
24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences